PETER SVENNILSON

Profile

First Name

: PETER

Middle Name

:

Last Name

: SVENNILSON

Related Companies
Titles
Company Name
Related People
DIRECTOR
FARALLON BIOSCIENCES, INC
ROBERT ADELMAN, ISAN CHEN, CAROL GALLAGHER, CARL GORDON, LEO A. GUTHART, FAHEEM HASNAIN, RICHARD A. HEYMAN, ANGIE YOU, BRETT ZBAR
DIRECTOR
NGM BIOPHARMACEUTICALS INC
LUIS BAYOL, JIN-LONG CHEN, DAVID GOEDDEL, DAVID V. GOEDDEL, HELEN KIM, MARC LESCHLY, MARK LESCHLY, ARTHUR LEVINSON, ARTHUR D. LEVINSON, WILLIAM RIEFLIN, WILLIAM J. RIEFLIN, DAVID SCHNELL, MCHENRY T. TICHENOR, JR.
EXECUTIVE OFFICER
COLUMN GROUP II, LP
HARALD EKMAN, DAVID GOEDDEL, PH.D., RICHARD KLAUSNER, M.D., MAGNUS PERSSON, M.D., PH.D.
DIRECTOR
ARAGON PHARMACEUTICALS, INC.
ROBERT ADELMAN, ISAN CHEN, CAROL GALLAGHER, CARL GORDON, LEO A. GUTHART, FAHEEM HASNAIN, RICHARD A. HEYMAN, ANGIE YOU, BRETT ZBAR
DIRECTOR
PTC THERAPEUTICS, INC.
RICHARD ALDRICH, NEIL ALMSTEAD, NEIL ALMSTEAD, PH.D, WILLIAM BAIRD, III, AXEL BOLTE, MARK E. BOULDING, SOREN CARLSEN, CARL GOLDFISCHER, EMILY HILL, CLAUDIA HIRAWAT, ALLAN S. JACOBSON, ALLAN JACOBSON, PH.D., MATTHEW KLEIN, MATTHEW B. KLEIN, MATTHEW B. KLEIN, M.D., ADAM KOPPEL, MICHAEL KRANDA, GEOFFREY MCDONOUGH, LANGDON L. MILLER, LANGON L. MILLER, STEPANIE S. OKEY, STEPHANIE S. OKEY, DEEPA PAKIANATHAN, ERIC PAUWELS, STUART W. PELTZ, EMMA REEVE, MICHAEL SCHMERTZLER, MARY SMITH, DAVID P. SOUTHWELL, MARCIO SOUZA, GLENN D. STEELE JR., M.D., PH.D., GLENN D. STEELE, JR., DAWN SVORONOS, CHRISTINE UTTER, ALETHIA YOUNG, JEROME B. ZELDIS, JEROME B. ZELDIS, M.D., PH.D.
DIRECTOR
IMMUNE DESIGN CORP.
BRIAN ATWOOD, BRIAN V ATWOOD, DAVID BALTIMORE, DAVID V BALTIMORE, FRANKLIN BERGER, STEPHEN R BRADY, STEPHEN R. BRADY, BRUCE CARTER, BRUCE LA CARTER, BRUCE V CARTER, THOMAS DUBENSKY, SAMMY FARAH, WAYNE GOMBOTZ, RICHARD T KENNEY, RICHARD T. KENNEY, RICHARD KLAUSNER, DAVID PARKER, CARLOS V PAYA, CARLOS V. PAYA, ED PENHOET, ED V PENHOET, EDWARD PENHOET, ROGER PERLMUTTER, STEVE REED, STEVEN REED, STEVEN G. REED, JAMES RICKEY, JAMES PAUL RICKEY, PAUL RICKEY, WILLIAM RINGO, ALAIN SCHREIBER, ALAIN V SCHREIBER, PETER V SVENNILSON, JAN HENRIK TER MEULEN
EXECUTIVE OFFICER
COLUMN GROUP II, LP
DAVID V. GOEDDEL, PH.D., TIM KUTZKEY, PH.D., LAURENCE LASKY, PH.D.
EXECUTIVE OFFICER
COLUMN GROUP III-A, LP
DAVID V GOEDDEL PH D, TIM KUTZKEY
EXECUTIVE OFFICER
COLUMN GROUP III, LP
DAVID V GOEDDEL PH D, TIM KUTZKEY
DIRECTOR
CONSTELLATION PHARMACEUTICALS INC
JAMES E. AUDIA, GAREN BOHLIN, SCOTT BRAUNSTEIN, MICHAEL R. COOPER, KEITH DIONNE, ANTHONY EVNIN, DAVID GOEDDEL, MARK A. GOLDSMITH, EDWARD E. HARLOW, JR., STEVEN HOERTER, MATTHIAS JAFFE, MARK LEVIN, TOM MANIATIS, STEVEN PAUL, JIGAR RAYTHATHA, EMMA REEVE, KERRY K. REINERTSEN, ADRIAN SENDEROWICZ, ROBERT TEPPER, ELIZABETH G. TREHU, PATRICK TROJER, KAREN VALENTINE
DIRECTOR
CIRCLE PHARMA, INC.
DOUGLAS CRAWFORD, DAVID EARP, DAVID J. EARP, JAMES EVANGELISTA, MATTHEW JACOBSON, MATTHEW P. JACOBSON, JOHN JOSEY, STEPHEN KELSEY, SCOTT R. LOKEY, CAYLA MCEWEN, WALTER MOOS, WALTER H. MOOS, PAUL PARK, ELTON SATUSKY, THILO SCHROEDER
DIRECTOR
CARMOT THERAPEUTICS INC.
DANIEL A. ERLANSON, TIMOTHY GARNETT, DAVE GOEDDEL, STIG K. HANSEN, STIG K. HANSEN, PH.D., TIM KUTZKEY, TIM KUTZKY, LARRY LASKY, MAGNUS PERSSON, ANNE PHILLIPS, M.D., AETNA WUN TROMBLEY, AETNA WUN TROMBLEY, HEATHER TURNER
EXECUTIVE OFFICER
COLUMN GROUP-NEURO, LP
DAVID V. GOEDDEL, PHD, TIM KUTZKEY, PHD
EXECUTIVE OFFICER
COLUMN GROUP V, LP
DAVID GOEDDEL, TIM KUTZKEY
EXECUTIVE OFFICER
COLUMN GROUP OPPORTUNITY III, LP
DAVID GOEDDEL, TIM KUTZKEY
EXECUTIVE OFFICER
COLUMN GROUP SPV I, LP
DAVID GOEDDEL, TIM KUTZKEY
EXECUTIVE OFFICER
COLUMN GROUP-NEURO II, LP
TIM KUTZKEY
DIRECTOR
NGM BIO HOLDINGS, INC.
DIANA PENG BOCKUS, KARA CALHOUN, DAVID GOEDDEL, SHELLY D. GUYER, CAROLE HO, DANIEL KAPLAN, TIM KUTZKEY, HSIAO D. LIEU, ROGER M. PERLMUTTER, VALERIE PIERCE, WILLIAM J. RIEFLIN, JEAN-FREDERIC VIRET, DAVID J. WOODHOUSE
DIRECTOR
NEURONA THERAPEUTICS, INC
DAVID GOEDDEL, LEO GUTHART, STEPHEN HAUSER, RAY KELLEHER, ARNOLD KRIEGSTEIN, ARNOLD R. KRIEGSTEIN, TIM KUTZKEY, BRAD MARGUS, CORY NICHOLAS, JAMES STUTZ, ROBERT TIJAN, ROBERT TJIAN, ERICA WHITAKER, ERICA WHITTAKER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-05 
2025-04-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-03-28 
2024-07-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-05 
2024-02-13
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2024-02-09 
2023-06-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-24 
2022-12-08
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-11-29 
2022-08-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-25 
2022-06-16
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2022-06-09 
2022-06-16
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2022-06-09 
2021-06-29
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2021-06-15 
2021-05-14
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2021-05-10 
2020-10-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-17 
2020-03-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-16 
2018-04-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-22 
2016-09-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-13 
2016-04-27
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-01 
2016-04-27
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-01 
2015-03-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-20 
2015-02-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-09 
2014-09-16
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-04 
2014-06-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-03-10 
2014-06-11
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-07-21 
2014-06-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2008-02-20 
2014-04-11
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-04 
2013-05-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-09 
2013-02-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-01-29 
2012-09-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-14 
2012-08-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-24 
2012-06-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-05-29 
2012-03-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-24 
2011-11-07
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-10 
2011-11-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-10 
2010-05-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-10 
2010-04-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-14 
2010-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-10 
2010-03-10
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-26 
2009-12-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-01-18 
2009-12-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-01-18 
2009-11-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-01-18 
2009-05-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-19